Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Kathleen Goin

COO at Palvella Therapeutics, Inc. (PVLA)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $5.5M

Reported trades

Filed Stock Type Shares Price Value Since
Sep 18SEC PVLAPalvella Therapeutics, Inc. Sell Plan 1,6592,643 held (−39%) $151.16 $251K -8.2%
Sep 18SEC PVLAPalvella Therapeutics, Inc. Sell Plan 9891,654 held (−37%) $152.36 $151K -8.9%
Sep 18SEC PVLAPalvella Therapeutics, Inc. Sell Plan 1,654 $153.24 $253K -9.4%
Aug 20SEC PVLAPalvella Therapeutics, Inc. Sell Plan 1,5002,802 held (−35%) $151.39 $227K -8.3%
Aug 20SEC PVLAPalvella Therapeutics, Inc. Sell Plan 1,998804 held (−71%) $151.80 $303K -8.6%
Aug 20SEC PVLAPalvella Therapeutics, Inc. Sell Plan 400404 held (−50%) $153.00 $61K -9.3%
Aug 20SEC PVLAPalvella Therapeutics, Inc. Sell Plan 102302 held (−25%) $155.59 $16K -10.8%
Aug 20SEC PVLAPalvella Therapeutics, Inc. Sell Plan 302 $156.77 $47K -11.5%
Jul 17SEC PVLAPalvella Therapeutics, Inc. Sell Plan 5223,780 held (−12%) $147.14 $77K -5.7%
Jul 17SEC PVLAPalvella Therapeutics, Inc. Sell Plan 8402,940 held (−22%) $148.40 $125K -6.5%
Jul 17SEC PVLAPalvella Therapeutics, Inc. Sell Plan 1,0291,911 held (−35%) $149.27 $154K -7.0%
Jul 17SEC PVLAPalvella Therapeutics, Inc. Sell Plan 1,911 $150.25 $287K -7.6%
Jun 22SEC PVLAPalvella Therapeutics, Inc. Sell Plan 2,3901,912 held (−56%) $110.26 $264K +25.9%
Jun 22SEC PVLAPalvella Therapeutics, Inc. Sell Plan 1,88725 held (−99%) $111.31 $210K +24.7%
Jun 22SEC PVLAPalvella Therapeutics, Inc. Sell Plan 25 $112.23 $3K +23.6%
May 22SEC PVLAPalvella Therapeutics, Inc. Sell Plan 3,363939 held (−78%) $110.35 $371K +25.8%
May 22SEC PVLAPalvella Therapeutics, Inc. Sell Plan 89148 held (−95%) $111.30 $99K +24.7%
May 22SEC PVLAPalvella Therapeutics, Inc. Sell Plan 48 $111.90 $5K +24.0%
Apr 17SEC PVLAPalvella Therapeutics, Inc. Sell Plan 1,5022,800 held (−35%) $125.96 $189K +10.2%
Apr 17SEC PVLAPalvella Therapeutics, Inc. Sell Plan 1,5001,300 held (−54%) $127.13 $191K +9.2%
Apr 17SEC PVLAPalvella Therapeutics, Inc. Sell Plan 561739 held (−43%) $128.23 $72K +8.2%
Apr 17SEC PVLAPalvella Therapeutics, Inc. Sell Plan 639100 held (−86%) $129.17 $83K +7.4%
Apr 17SEC PVLAPalvella Therapeutics, Inc. Sell Plan 100 $130.33 $13K +6.5%
Mar 20SEC PVLAPalvella Therapeutics, Inc. Sell Plan 2,2682,034 held (−53%) $117.56 $267K +18.0%
Mar 20SEC PVLAPalvella Therapeutics, Inc. Sell Plan 1,730304 held (−85%) $118.37 $205K +17.2%
Mar 20SEC PVLAPalvella Therapeutics, Inc. Sell Plan 304 $119.08 $36K +16.5%
Feb 20SEC PVLAPalvella Therapeutics, Inc. Sell Plan 3,0261,276 held (−70%) $79.16 $240K +75.3%
Feb 20SEC PVLAPalvella Therapeutics, Inc. Sell Plan 1,276 $79.97 $102K +73.5%
Jan 23SEC PVLAPalvella Therapeutics, Inc. Sell Plan 5533,749 held (−13%) $95.49 $53K +45.3%
Jan 23SEC PVLAPalvella Therapeutics, Inc. Sell Plan 3,749 $97.94 $367K +41.7%
Dec 19SEC PVLAPalvella Therapeutics, Inc. Sell Plan 4,302 $96.47 $415K +43.8%
Nov 21SEC PVLAPalvella Therapeutics, Inc. Sell Plan 1,5002,802 held (−35%) $85.72 $129K +61.9%
Nov 21SEC PVLAPalvella Therapeutics, Inc. Sell Plan 2,802 $86.51 $242K +60.4%
  • Sell

    COO Kathleen Goin sold $251K of PVLA at $151.16 — cuts the stake by 39%; pre-scheduled 10b5-1 plan sale.

  • Sell

    COO Kathleen Goin sold $151K of PVLA at $152.36 — cuts the stake by 37%; pre-scheduled 10b5-1 plan sale.

  • Sell

    COO Kathleen Goin sold $253K of PVLA at $153.24 — pre-scheduled 10b5-1 plan sale.

  • Sell

    COO Kathleen Goin sold $227K of PVLA at $151.39 — cuts the stake by 35%; pre-scheduled 10b5-1 plan sale.

  • Sell

    COO Kathleen Goin sold $303K of PVLA at $151.80 — cuts the stake by 71%; pre-scheduled 10b5-1 plan sale.

  • Sell

    COO Kathleen Goin sold $61K of PVLA at $153.00 — cuts the stake by 50%; pre-scheduled 10b5-1 plan sale.